Callaway Nursing Home
Inspection Findings
F-Tag F0684
F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
record review and interview, the facility failed to follow physician orders for administering medication for 1 (#2) of 4 sampled residents reviewed for following physician orders. The administrator identified 51 residents resided in the facility. Findings: Resident #2's hospital discharge papers, dated 08/21/25, showed
the resident was diagnosed and treated for bacterial pneumonia during the hospital stay. A health status note, dated 08/21/25 6:24 p.m., showed Resident #2 was re-admitted to the facility on [DATE REDACTED].The hospital discharge medication list, dated 08/21/25, showed the resident should had received the following new medications which had not been added to the resident's physician orders upon readmission to the facility: a. Albuterol (bronchodilator) 0.083 % Inhalation Solution, 3 milliliters HHN every 4 hours as needed;b. bumetanide (diuretic) AvPak, 0.5 mg orally twice daily;c. Cobenfy (antipsychotic) 125 mg-30 mg, one capsule orally twice daily;d. digoxin (used to strengthen the heart) 0.125 mg, 0.25 mg daily at noon;e. divalproex Sodium (anticonvulsant) AvPak 500 mg, extended release, 1500 mg orally daily;f. hydrochlorothiazide (diuretic) 25 mg, 25 mg orally daily;g. Klor-Con (potassium supplement) 20 meq, extended release, 40 meq orally twice daily;h. lacosamide (anticonvulsant) 200 mg, 200 mg orally twice daily;i. lactobacillus (bacteria to aide in digestion) 0.05 mg-0.05 mg, one tablet orally twice daily;j.
Levalbuterol (bronchodilator) 1.25 mg, 1.25 mg HHN twice daily;k. magnesium Glycinate (magnesium supplement) 100 mg, 400 mg orally twice daily;l. midodrine HCL (antihypotensive) 5 mg, 2.5 mg orally three times daily;m. Miralax (laxative) 17 gram/1 dose oral powder for solution, orally twice daily;n. tamsulosin HCL (treatment of benign prostatic hyperplasia) 0.4 mg, 0.4 mg orally at bedtime;o. trospium Chloride (treatment of overactive bladder) 20 mg, 20 mg orally daily;p. clozapine (antipsychotic) had been changed from 50 mg, 3 tablets at bedtime to clozapine 25 mg at bedtime; andq. risperidone (antipsychotic) was changed from 3 mg, 2 tablets daily to risperidone 1 mg, give 3 mg daily.A health status note, dated 08/23/25 2:17 p.m., showed Resident #2's physician gave an order for the resident to be transferred to the emergency room due to respiratory concerns. On 10/27/25 at 1:10 p.m., the DON stated the medication additions to Resident #2's physician ordered medication list should have been added and given to the resident. The DON stated none of the above listed medications had been given as ordered by the physician upon Resident #2's readmission to the facility from the hospital on [DATE REDACTED] until their discharge to the hospital again on 8/23/25.
Residents Affected - Few
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99) Previous Versions Obsolete
Facility ID:
If continuation sheet
Event ID:
37E624
CALLAWAY NURSING HOME in SULPHUR, OK inspection on recent inspection.
Found 0 violation(s). Severity: Standard violations. Status: 0 corrected, 0 pending.
Frequently Asked Questions
- What is an F-tag violation?
- F-tags are federal deficiency codes used by CMS to categorize nursing home violations. Each F-tag corresponds to a specific federal regulation (42 CFR Part 483). For example, F607 relates to abuse prevention policies, F880 relates to infection control.
- Were these violations corrected?
- Facilities must submit plans of correction and implement changes within required timeframes. CMS conducts follow-up inspections to verify corrections. Check the inspection report for specific correction dates and follow-up verification status.
- How often do nursing home inspections happen?
- CMS conducts unannounced inspections of all Medicare/Medicaid-certified nursing homes at least once per year. Additional inspections may occur based on complaints, facility-reported incidents, or follow-up to verify previous violations were corrected.
- What should families do about these violations?
- Families should: (1) Review the full inspection report for details, (2) Ask facility administration about specific corrective actions taken, (3) Check if this represents a pattern by reviewing prior inspections, (4) Compare with other facilities in SULPHUR, OK, (5) Report new concerns to state authorities.
- Where can I see the full inspection report?
- Complete inspection reports are available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request copies directly from CALLAWAY NURSING HOME or from the state Department of Health. Reports include deficiency codes, facility responses, and correction timelines.